Special Issue “Diabetes: Comorbidities, Therapeutics and Insights”
Conflicts of Interest
List of Contributions
- Butuca, A.; Dobrea, C.M.; Arseniu, A.M.; Frum, A.; Chis, A.A.; Rus, L.L.; Ghibu, S.; Juncan, A.M.; Muntean, A.C.; Lazăr, A.E.; et al. An Assessment of Semaglutide Safety Based on Real World Data: From Popularity to Spontaneous Reporting in EudraVigilance Database. Biomedicines 2024, 12, 1124. https://doi.org/10.3390/biomedicines12051124.
- Li, Y.-H.; Cheng, Y.-C.; Liu, H.-C.; Wu, J.; Lee, I.-T. Depressive Symptoms Associated with Peripheral Artery Disease and Predicting Mortality in Type 2 Diabetes. Biomedicines 2024, 12, 29. https://doi.org/10.3390/biomedicines12010029.
- Klimontov, V.V.; Mavlianova, K.R.; Orlov, N.B.; Semenova, J.F.; Korbut, A.I. Serum Cytokines and Growth Factors in Subjects with Type 1 Diabetes: Associations with Time in Ranges and Glucose Variability. Biomedicines 2023, 11, 2843. https://doi.org/10.3390/biomedicines11102843.
- Wu, T.; Wang, Q.; Pu, C.; Zhang, K. The Correlation between Islet β Cell Secretion Function and Gallbladder Stone Disease: A Retrospective Study Based on Chinese Patients with Newly Diagnosed Type 2 Diabetes Mellitus. Biomedicines 2023, 11, 2840. https://doi.org/10.3390/biomedicines11102840.
- Fedulovs, A.; Tzivian, L.; Zalizko, P.; Ivanova, S.; Bumane, R.; Janeviča, J.; Krūzmane, L.; Krustins, E.; Sokolovska, J. Progression of Diabetic Kidney Disease and Gastrointestinal Symptoms in Patients with Type I Diabetes. Biomedicines 2023, 11, 2679. https://doi.org/10.3390/biomedicines11102679.
- Bulum, T.; Vučić Lovrenčić, M.; Knežević Ćuća, J.; Tomić, M.; Vučković-Rebrina, S.; Duvnjak, L. Relationship between β-Cell Autoantibodies and Their Combination with Anthropometric and Metabolic Components and Microvascular Complications in Latent Autoimmune Diabetes in Adults. Biomedicines 2023, 11, 2561. https://doi.org/10.3390/biomedicines11092561.
- Liu, T.; Zhuang, X.-X.; Gao, J.-R. Identifying Aging-Related Biomarkers and Immune Infiltration Features in Diabetic Nephropathy Using Integrative Bioinformatics Approaches and Machine-Learning Strategies. Biomedicines 2023, 11, 2454. https://doi.org/10.3390/biomedicines11092454.
- Greco, S.; Monda, V.M.; Valpiani, G.; Napoli, N.; Crespini, C.; Pieraccini, F.; Marra, A.; Passaro, A. The Impact of GLP-1 RAs and DPP-4is on Hospitalisation and Mortality in the COVID-19 Era: A Two-Year Observational Study. Biomedicines 2023, 11, 2292. https://doi.org/10.3390/biomedicines11082292.
- Kondo, M.; Sawada, K.; Matsuda, Y.; Abe, M.; Sanechika, N.; Takanashi, Y.; Mori, Y.; Kimura, M.; Toyoda, M. Study of the Effects of Deuterium-Depleted Water on the Expression of GLUT4 and Insulin Resistance in the Muscle Cell Line C2C12. Biomedicines 2024, 12, 1771. https://doi.org/10.3390/biomedicines12081771.
- Aburisheh, K.H.; Barhoush, M.M.; Alahmari, A.N.; Altasan, Z.A.; Alharthi, M.H. Neonatal Outcomes in Patients with Gestational Diabetes Mellitus Treated with Metformin: A Retrospective Study in Saudi Arabia. Biomedicines 2024, 12, 2040. https://doi.org/10.3390/biomedicines12092040.
- Basiri, R.; Rajanala, Y.; Kassem, M.; Cheskin, L.J.; Frankenfeld, C.L.; Farvid, M.S. Diabetes Control Status and Severity of Depression: Insights from NHANES 2005–2020. Biomedicines 2024, 12, 2276. https://doi.org/10.3390/biomedicines12102276.
- Vargas Guerrero, M.G.; Vonken, L.; Peters, E.; Lucchesi, J.; Arts, J.J.C. Material Technologies for Improved Diabetic Foot Ulcer (DFU) Treatment: A Questionnaire Study of Healthcare Professionals’ Needs. Biomedicines 2024, 12, 2483. https://doi.org/10.3390/biomedicines12112483.
- Alshawaf, E.; Marafie, S.K.; Abu-Farha, M.; Albatineh, A.N.; Alramah, T.; Albuhairi, A.; Al Qassar, Y.; Zinoun, R.; Shalabi, R.; Behbehani, S.; et al. Circulating Isthmin-1 Levels and Their Relationship with Diabetes and Metabolic Diseases in Kuwaiti Adults. Biomedicines 2025, 13, 101. https://doi.org/10.3390/biomedicines13010101.
- Perrelli, M.; Goparaju, P.; Postolache, T.T.; del Bosque-Plata, L.; Gragnoli, C. Stress and the CRH System, Norepinephrine, Depression, and Type 2 Diabetes. Biomedicines 2024, 12, 1187. https://doi.org/10.3390/biomedicines12061187.
- Navasardyan, I.; Yeganyan, S.; Nguyen, H.; Vaghashia, P.; Subbian, S.; Venketaraman, V. Role of Oxidative Stress in Tuberculosis Meningitis Infection in Diabetics. Biomedicines 2023, 11, 2568. https://doi.org/10.3390/biomedicines11092568.
- Caturano, A.; Galiero, R.; Rocco, M.; Tagliaferri, G.; Piacevole, A.; Nilo, D.; Di Lorenzo, G.; Sardu, C.; Vetrano, E.; Monda, M.; et al. Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care. Biomedicines 2024, 12, 2039. https://doi.org/10.3390/biomedicines12092039.
- Ayesh, H.; Suhail, S.; Ayesh, S.; Niswender, K. Comparative Efficacy and Safety of Weekly GLP-1/GIP Agonists vs. Weekly Insulin in Type 2 Diabetes: A Network Meta-Analysis of Randomized Controlled Trials. Biomedicines 2024, 12, 1943. https://doi.org/10.3390/biomedicines12091943.
References
- GBD 2021 Diabetes Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021. Lancet 2023, 402, 203–234. [Google Scholar] [CrossRef]
- International Diabetes Federation. IDF Diabetes Atlas, 10th ed.; International Diabetes Federation: Brussels, Belgium, 2021; Available online: http://www.diabetesatlas.org/ (accessed on 1 October 2023).
- Sun, H.; Saeedi, P.; Karuranga, S.; Pinkepank, M.; Ogurtsova, K.; Duncan, B.B.; Stein, C.; Basit, A.; Chan, J.C.N.; Mbanya, J.C.; et al. IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res. Clin. Pract. 2022, 183, 109119. [Google Scholar] [CrossRef]
- Harding, J.L.; Pavkov, M.E.; Magliano, D.J.; Shaw, J.E.; Gregg, E.W. Global trends in diabetes complications: A review of current evidence. Diabetologia 2019, 62, 3–16. [Google Scholar] [CrossRef]
- Flaxman, S.R.; Bourne, R.R.A.; Resnikoff, S.; Ackland, P.; Braithwaite, T.; Cicinelli, M.V.; Das, A.; Jonas, J.B.; Keeffe, J.; Kempen, J.H.; et al. Vision Loss Expert Group of the Global Burden of Disease Study. Global causes of blindness and distance vision impairment 1990-2020: A systematic review and meta-analysis. Lancet Glob. Health 2017, 5, e1221–e1234. [Google Scholar] [CrossRef]
- Ben-David, E.; Hull, R.; Banerjee, D. Diabetes mellitus in dialysis and renal transplantation. Ther. Adv. Endocrinol. Metab. 2021, 12, 20420188211048663. [Google Scholar] [CrossRef]
- Ezzatvar, Y.; García-Hermoso, A. Global estimates of diabetes-related amputations incidence in 2010-2020: A systematic review and meta-analysis. Diabetes Res. Clin. Pract. 2023, 195, 110194. [Google Scholar] [CrossRef] [PubMed]
- Armstrong, D.G.; Tan, T.W.; Boulton, A.J.M.; Bus, S.A. Diabetic Foot Ulcers: A Review. JAMA 2023, 330, 62–75. [Google Scholar] [CrossRef]
- Vella, S.; Petrie, J.R. Macrovascular disease: Pathogenesis and risk assessment. Medicine 2022, 11, 683–690. [Google Scholar] [CrossRef]
- Rajbhandari, J.; Fernandez, C.J.; Agarwal, M.; Yeap, B.X.Y.; Pappachan, J.M. Diabetic heart disease: A clinical update. World J. Diabetes 2021, 12, 383–406. [Google Scholar] [CrossRef] [PubMed]
- Sebastian, S.A.; Padda, I.; Johal, G. Cardiovascular-Kidney-Metabolic (CKM) syndrome: A state-of-the-art review. Curr. Probl. Cardiol. 2024, 49, 102344. [Google Scholar] [CrossRef] [PubMed]
- Wang, C.; Ye, D.; Xie, Z.; Huang, X.; Wang, Z.; Shangguan, H.; Zhu, W.; Wang, S. Assessment of Cardiovascular Risk Factors and Their Interactions in the Risk of Coronary Heart Disease in Patients with Type 2 Diabetes with Different Weight Levels, 2013–2018. Diabetes Metab. Syndr. Obes. 2021, 14, 4253–4262. [Google Scholar] [CrossRef] [PubMed]
- Rolek, B.; Haber, M.; Gajewska, M.; Rogula, S.; Pietrasik, A.; Gąsecka, A. SGLT2 Inhibitors vs. GLP-1 Agonists to Treat the Heart, the Kidneys and the Brain. J. Cardiovasc. Dev. Dis. 2023, 10, 322. [Google Scholar] [CrossRef]
- Wai, K.M.; Mishra, K.; Koo, E.; Ludwig, C.A.; Parikh, R.; Mruthyunjaya, P.; Rahimy, E. Impact of GLP-1 Agonists and SGLT-2 Inhibitors on Diabetic Retinopathy Progression: An Aggregated Electronic Health Record Data Study. Am. J. Ophthalmol. 2024, 265, 39–47. [Google Scholar] [CrossRef]
- Eleftheriadou, A.; Riley, D.; Zhao, S.S.; Austin, P.; Hernández, G.; Lip, G.Y.H.; Jackson, T.L.; Wilding, J.P.H.; Alam, U. Risk of diabetic retinopathy and diabetic macular oedema with sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 diabetes: A real-world data study from a global federated database. Diabetologia 2024, 67, 1271–1282. [Google Scholar] [CrossRef]
- Aune, D.; Vatten, L.J. Diabetes mellitus and the risk of gallbladder disease: A systematic review and meta-analysis of prospective studies. J. Diabetes Complicat. 2016, 30, 368–373. [Google Scholar] [CrossRef] [PubMed]
- Redondo, M.J. LADA: Time for a new definition. Diabetes 2013, 62, 339–340. [Google Scholar] [CrossRef] [PubMed]
- Buzzetti, R.; Tuomi, T.; Mauricio, D.; Pietropaolo, M.; Zhou, Z.; Pozzilli, P.; Leslie, R.D. Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel. Diabetes 2020, 69, 2037–2047. [Google Scholar] [CrossRef] [PubMed]
- Somlyai, G.; Somlyai, I.; Fórizs, I.; Czuppon, G.; Papp, A.; Molnár, M. Effect of Systemic Subnormal Deuterium Level on Metabolic Syndrome Related and other Blood Parameters in Humans: A Preliminary Study. Molecules 2020, 25, 1376. [Google Scholar] [CrossRef]
- Meurs, M.; Roest, A.M.; Wolffenbuttel, B.H.R.; Stolk, R.P.; de Jonge, P.; Rosmalen, J.G.M. Association of Depressive and Anxiety Disorders with Diagnosed versus Undiagnosed Diabetes: An Epidemiological Study of 90,686 Participants. Psychosom. Med. 2016, 78, 233–241. [Google Scholar] [CrossRef]
- Chen, L.; Sun, S.; Gao, Y.; Ran, X. Global mortality of diabetic foot ulcer: A systematic review and meta-analysis of observational studies. Diabetes Obes. Metab. 2023, 25, 36–45. [Google Scholar] [CrossRef]
- Ma, C.X.; Ma, X.N.; Guan, C.H.; Li, Y.D.; Mauricio, D.; Fu, S.B. Cardiovascular disease in type 2 diabetes mellitus: Progress toward personalized management. Cardiovasc. Diabetol. 2022, 21, 74. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Bulum, T. Special Issue “Diabetes: Comorbidities, Therapeutics and Insights”. Biomedicines 2025, 13, 2043. https://doi.org/10.3390/biomedicines13092043
Bulum T. Special Issue “Diabetes: Comorbidities, Therapeutics and Insights”. Biomedicines. 2025; 13(9):2043. https://doi.org/10.3390/biomedicines13092043
Chicago/Turabian StyleBulum, Tomislav. 2025. "Special Issue “Diabetes: Comorbidities, Therapeutics and Insights”" Biomedicines 13, no. 9: 2043. https://doi.org/10.3390/biomedicines13092043
APA StyleBulum, T. (2025). Special Issue “Diabetes: Comorbidities, Therapeutics and Insights”. Biomedicines, 13(9), 2043. https://doi.org/10.3390/biomedicines13092043